RETRACTION: Comparison of Topical 0.3% Ofloxacin to Fortified Tobramycin - Cefazolin in the Therapy of Bacterial Keratitis (Retraction of Vol 28, Pg 149, 2000)

被引:0
|
作者
Khokhar, S. [1 ]
Sindhu, N. [1 ]
Mirdha, B. R. [2 ]
机构
[1] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India
关键词
D O I
10.1007/s15010-024-02212-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:2005 / 2005
页数:1
相关论文
共 29 条
  • [1] Comparison of topical 0.3% ofloxacin cefazolin in the fortified tobramycin - Cefazolin therapy of bacterial keratitis
    Khokhar, S
    Sindhu, N
    Mirdha, BR
    INFECTION, 2000, 28 (03) : 149 - 152
  • [2] RETRACTED ARTICLE: Comparison of Topical 0.3% Ofloxacin to Fortified Tobramycin – Cefazolin in the Therapy of Bacterial Keratitis
    S. Khokhar
    N. Sindhu
    B.R. Mirdha
    Infection, 2000, 28 : 149 - 152
  • [3] Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis
    Panda, A
    Ahuja, R
    Sastry, SS
    EYE, 1999, 13 (6) : 744 - 747
  • [4] Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis
    Anita Panda
    Rakesh Ahuja
    S Srinivas Sastry
    Eye, 1999, 13 : 744 - 747
  • [6] Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis
    Baker, RS
    Flowers, CW
    Casey, R
    Fong, DS
    Wilson, MR
    ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (05) : 632 - 632
  • [7] A comparison of topical chlorhexidine, ciprofloxacin, and fortified Tobramycin/Cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis
    Bu, Ping
    Riske, Paul S.
    Zaya, Ninef E.
    Carey, Roberta
    Bouchard, Charles S.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (03) : 213 - 220
  • [8] EFFICACY OF OFLOXACIN VS CEFAZOLIN AND TOBRAMYCIN IN THE THERAPY FOR BACTERIAL KERATITIS - REPORT FROM THE BACTERIAL-KERATITIS-STUDY-RESEARCH-GROUP
    OBRIEN, TP
    MAGUIRE, MG
    FINK, NE
    ALFONSO, E
    MCDONNELL, P
    SHEPPARD, JD
    BODNER, BI
    RUSCH, A
    OLSON, RJ
    LUCIUS, R
    JACKSON, A
    LOIDENIX, M
    MAMALIS, N
    KEANEY, R
    PFLUGFELDER, S
    FORSTER, RK
    HUANG, A
    DELCALVO, M
    SUTPHIN, J
    DOHODA, R
    BLANTON, C
    TANNER, G
    GOTTSCH, D
    STARK, WJ
    LIVINGSTON, A
    BELIN, MW
    GARZA, D
    CUNNINGHAM, RD
    CROFT, K
    PENNELL, J
    KIRKPATRICK, P
    LUSTBADER, J
    LEMP, M
    PLAVNIEKS, S
    FARRELL, P
    SOONG, HK
    MEYER, RF
    SUGAR, A
    WALDO, M
    STAMLER, JF
    VERDIER, DD
    PERRY, H
    DONNENFELD, E
    KENYON, K
    RAPOZA, P
    MILLER, D
    KENNEALLY, M
    GRENE, RB
    WELLEMEYER, M
    LANKSTON, P
    ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (10) : 1257 - 1265
  • [9] Comparison of topical chlorhexidine. ciprofloxacin. and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis
    Riske, PS
    Bu, P
    Bouchard, CS
    Zaya, N
    Carey, RB
    Creech, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U349 - U349
  • [10] Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers
    Hyndiuk, RA
    Eiferman, RA
    Caldwell, DR
    Rosenwasser, GO
    Santos, CI
    Katz, HR
    Badrinath, SS
    Reddy, MK
    Adenis, JP
    Klauss, V
    COhen, E
    MarechalCourtois, C
    Murta, J
    Darrell, RW
    Denis, P
    Heidemann, DH
    Insler, MS
    John, T
    Klauss, V
    Lass, JH
    Limberg, MB
    McCulley, JP
    Rosenwasser, GOD
    Rowsey, JJ
    Santos, C
    Sher, N
    Ullman, S
    Verin, P
    Wilhelmus, KR
    Wills, R
    Wolf, TC
    OPHTHALMOLOGY, 1996, 103 (11) : 1854 - 1862